262 related articles for article (PubMed ID: 34167561)
1. Prognostic significance of CD163+ tumor-associated macrophages in colorectal cancer.
Xue T; Yan K; Cai Y; Sun J; Chen Z; Chen X; Wu W
World J Surg Oncol; 2021 Jun; 19(1):186. PubMed ID: 34167561
[TBL] [Abstract][Full Text] [Related]
2. Elevated CD163
Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B
Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919
[No Abstract] [Full Text] [Related]
3. Tumor-associated macrophage infiltration and prognosis in colorectal cancer: systematic review and meta-analysis.
Li J; Li L; Li Y; Long Y; Zhao Q; Ouyang Y; Bao W; Gong K
Int J Colorectal Dis; 2020 Jul; 35(7):1203-1210. PubMed ID: 32303831
[TBL] [Abstract][Full Text] [Related]
4. The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer.
Xu G; Jiang L; Ye C; Qin G; Luo Z; Mo Y; Chen J
Front Immunol; 2021; 12():724429. PubMed ID: 34512652
[TBL] [Abstract][Full Text] [Related]
5. CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood.
Krijgsman D; De Vries NL; Andersen MN; Skovbo A; Tollenaar RAEM; Møller HJ; Hokland M; Kuppen PJK
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824692
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the infiltration of CD163
Huang X; Pan Y; Ma J; Kang Z; Xu X; Zhu Y; Chen J; Zhang W; Chang W; Zhu J
Cancer Med; 2018 May; 7(5):1731-1741. PubMed ID: 29573574
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value and predictive biomarkers of phenotypes of tumour-associated macrophages in colorectal cancer.
Kou Y; Li Z; Sun Q; Yang S; Wang Y; Hu C; Gu H; Wang H; Xu H; Li Y; Han B
Scand J Immunol; 2022 Apr; 95(4):e13137. PubMed ID: 34964155
[TBL] [Abstract][Full Text] [Related]
8. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
Medrek C; Pontén F; Jirström K; Leandersson K
BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
[TBL] [Abstract][Full Text] [Related]
9. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer.
Edin S; Wikberg ML; Dahlin AM; Rutegård J; Öberg Å; Oldenborg PA; Palmqvist R
PLoS One; 2012; 7(10):e47045. PubMed ID: 23077543
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma.
Kim KJ; Wen XY; Yang HK; Kim WH; Kang GH
PLoS One; 2015; 10(12):e0144192. PubMed ID: 26714314
[TBL] [Abstract][Full Text] [Related]
11. Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.
Abd Allah MYY; Fahmi MW; El-Ashwah S
J Egypt Natl Canc Inst; 2020 Apr; 32(1):18. PubMed ID: 32372254
[TBL] [Abstract][Full Text] [Related]
12. CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast.
Jamiyan T; Kuroda H; Yamaguchi R; Abe A; Hayashi M
Virchows Arch; 2020 Dec; 477(6):767-775. PubMed ID: 32607685
[TBL] [Abstract][Full Text] [Related]
13. The correlation between infiltration of FoxP3
Ren Y; Chen Z; Sun J; Cai Y; Chen Z; Chen X; Wu W
Cent Eur J Immunol; 2022; 47(1):1-7. PubMed ID: 35600158
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
Bisheshar SK; van der Kamp MF; de Ruiter EJ; Ruiter LN; van der Vegt B; Breimer GE; Willems SM
Oral Oncol; 2022 Dec; 135():106227. PubMed ID: 36335818
[TBL] [Abstract][Full Text] [Related]
15. Impact of thymidine phosphorylase and CD163 expression on prognosis in stage II colorectal cancer.
Kaidi D; Szeponik L; Yrlid U; Wettergren Y; Bexe Lindskog E
Clin Transl Oncol; 2022 Sep; 24(9):1818-1827. PubMed ID: 35567733
[TBL] [Abstract][Full Text] [Related]
16. Role of tumor-associated macrophages at the invasive front in human colorectal cancer progression.
Inagaki K; Kunisho S; Takigawa H; Yuge R; Oka S; Tanaka S; Shimamoto F; Chayama K; Kitadai Y
Cancer Sci; 2021 Jul; 112(7):2692-2704. PubMed ID: 33964093
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer.
Waniczek D; Lorenc Z; Śnietura M; Wesecki M; Kopec A; Muc-Wierzgoń M
Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):445-454. PubMed ID: 28343267
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated CD163
Yoshida C; Kadota K; Yamada K; Fujimoto S; Ibuki E; Ishikawa R; Haba R; Yokomise H
Lung Cancer; 2022 May; 167():34-40. PubMed ID: 35395482
[TBL] [Abstract][Full Text] [Related]
19. CD163
Omilian AR; Cannioto R; Mendicino L; Stein L; Bshara W; Qin B; Bandera EV; Zeinomar N; Abrams SI; Hong CC; Yao S; Khoury T; Ambrosone CB
Breast Cancer Res; 2024 May; 26(1):75. PubMed ID: 38720366
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]